https://pubmed.ncbi.nlm.nih.gov/26721396/
Ras GTPase-activating proteins (GAPs) are important regulators for Ras activation, which is instrumental in tumor development. However, the mechanism...
egfrphosphorylatespromoterasactivation
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egfr-tyrosine-kinase-inhibitor
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
tyrosine kinase inhibitordefinitionegfrncidictionary
https://www.news-medical.net/news/20241114/Scientists-map-cancer-mutations-in-EGFR-gene-revealing-drug-resistance-paths.aspx
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance, paving the way for personalized...
egfr genedrug resistancescientistsmapcancer
https://www.mdanderson.org/newsroom/poziotinib-is-active-in-egfr-exon-20-mutant-non-small-cell-lung-cancer.h00-159541323.html
Jul 11, 2022 - A Phase II clinical trial of poziotinib for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 mutations, led by...
poziotinibactiveegfrexonmutant
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00074/full
Although the molecular landscape of squamous cell carcinoma of the head and neck (SCCHN) has been largely deciphered, only one targeted therapy has been appr...
frontiersbeyondegfrtargetingscchn
https://www.rcsb.org/structure/6JXT
Crystal structure of EGFR 696-1022 WT in complex with AZD9291 prepared by cocrystallization
crystal structurercsbpdbegfrwt
https://www.mdpi.com/1420-3049/24/3/647
Non-small cell lung cancer (NSCLC) patients carrying an epidermal growth factor receptor (EGFR) mutation are initially sensitive to EGFR-tyrosine kinase...
cucurbitacin binduceslysosomaldegradationegfr
https://www.ccralliance.org/ce
Your donation accelerates the research and clinical trial to bring a highly promising EGFR/HER2 vaccine immunotherapy to dogs with aggressive cancer.
egfrvaccineresearchgive
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2019-07941&r=1
Osimertinib with or without Bevacizumab as Initial Treatment for Patients with EGFR-Mutant Lung Cancer
osimertinibwithoutbevacizumabinitialtreatment
https://www.ncbi.nlm.nih.gov/Structure/cdd/cd12087
cd12087 (PSSM ID: 213052): Conserved Protein Domain Family TM_EGFR-like, PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr)...
conserved proteincdddomainfamilytm
https://pubmed.ncbi.nlm.nih.gov/34455066/
These results provide preliminary evidence that intracranial activity of CNS-penetrant TKIs may enable local radiation to be deferred in appropriately selected...
brain metastasesegfralkpositivensclc
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egfr-inhibitor
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
egfr inhibitordefinitionncidictionarycancer
https://phenotypes.mpog.org/Preop%20EGFR%20(Most%20Recent)
Web Site Builder Description
most recentpreopegfr
https://www.takeda.com/newsroom/newsreleases/2021/takeda-presents-positive-results-for-mobocertinib-in-patients-with-egfr-exon20-insertion-mnsclc-who-received-prior-platinum-based-chemotherapy/
Takeda Presents Positive Results for Mobocertinib in Patients with EGFR Exon20 Insertion+ mNSCLC who Received Prior Platinum-Based Chemotherapy
results fortakedapresentspositivemobocertinib